This is early beta for now! Can't handle all templates properly
Hankkija
Vastaanotettu Hilmaan | 2019-12-31 |
Ilmoituksen numero | 2019-008951 |
TED numero | 2019/S 080-191773 |
Ostajaorganisaatio | National Institute for Health and Welfare (2229500-6 ) PL 30 FI-00271 Helsinki https://thl.fi/en/web/thlfi-en |
Hankinnan otsikkotiedot | Quadrivalent Seasonal Influenza Vaccine 2019-2020 |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) arvio | |
Hankinnan yhteenlaskettu kokonaisarvo koko ajalle (ilman alv:ta) lopullinen | 27 676 000 EUR |
Alkuperäinen ilmoitus | https://www.hankintailmoitukset.fi/en/public/procurement/12720/notice/21232/overview |
Originaali JSON tietue | 21232.json |
Ostettava
Hankinnan lyhyt kuvaus | The purpose of STM and the Customer is to procure Quadrivalent Seasonal Influenza Vaccine required and suitable for the National Vaccination Programme in Finland for active immunisation of adults and children from six (6) months of age and older for the prevention of influenza disease. The Customer will implement the procurement on STM´s side. The contract will be awarded to one Supplier based on a comparison of tenders. Tenders will be compared in the manner described in section "Grounds for decision" of the Call for tenders. Estimated quantity for the contract period is 1 700 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The estimated duration of the contract is one year. The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. |
Hankintanimikkeistö (CPV) pää | |
Hankintanimikkeistö (CPV) muut | |
Aluekoodi | FI |
Pääasiallinen suorituspaikka |
Sopimukset
Päätös päivämäärä | 2019-04-10 |
Sopimusnumero | |
Myyjät | Sanofi Oy (FI), 1048723-8 |